Diagnostic significance of CA-62 cancer antigen for early detection and differential diagnosis of non-small cell lung cancer: results of the blind clinical trials

Diagnostic significance of CA-62 cancer antigen for early detection and differential diagnosis of non-small cell lung cancer: results of the blind clinical trials

Background. The combination of several diagnostic methods is used to predict treatment outcomes, assess overall survival, and increase the positive predictive value of detecting malignant lung and bronchial tumors. Aim. To evaluate the diagnostic value of the CLIA-СА-62 chemiluminescence immunoas...

Full description

Bibliographic Details
Main Authors: Janneta R. Tcherkassova, Anna I. Prostyakova, Sergei A. Tsurkan, Nikolai V. Suganov, Alexander M. Boroda, Angelina V. Zhilenkova, Juliya N. Pirogova, Zaiana D. Sangadzhieva, Aleksandr S. Rusanov, Aleksandr A. Rozhkov, Anastasia S. Fatyanova, Natalia M. Nikitina, Nikolay N. Bagmet, Marina I. Sekacheva
Format: Article
Language:Russian
Published: IP Habib O.N. 2023-05-01
Series:Современная онкология
Subjects:
ca-62 glycoprotein
non-small cell lung cancer
early diagnosis
lung cancer risk assessment
clinical study
clia-са-62 chemiluminescence immunoassay kit
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/241215/pdf

Internet

https://modernonco.orscience.ru/1815-1434/article/viewFile/241215/pdf

Similar Items